CPC C12Q 1/6886 (2013.01) [C12Q 1/06 (2013.01); G01N 33/53 (2013.01); G01N 37/00 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01)] | 6 Claims |
1. A method for detecting stomach cancer in a human subject, comprising:
measuring an expression level of hsa-miR-718 in a blood, serum or plasma sample from the subject;
comparing the measured expression level of hsa-miR-718 to a control expression level for a healthy subject;
detecting an increased level of hsa-miR-718 in the sample from the subject as compared to the control expression level from the sample from the healthy subject;
wherein the increased level of hsa-miR-718 indicates that the subject has stomach cancer; and
wherein the method further comprises treating the subject for the stomach cancer or performing a diagnostic procedure on the subject with the stomach cancer;
wherein the treating comprises surgery, radiotherapy, chemotherapy or a combination thereof; and
wherein the diagnostic procedure comprises gastric X-ray examination, gastroscopy, or imaging of the stomach.
|